Atrial fibrillation
Atrial fibrillation (AF) is one of the most common arrhythmias. It is caused by many small reentry loops caused by the dominant reentry loop of the atrium. The overall incidence of AF is 0.4%. The incidence of AF increases with age and can reach 10% in people over 75 years old. During AF, the frequency of atrial excitation reaches 300-600 beats/min. The heart rate is often fast and irregular, sometimes reaching 100-160 beats/min. It is not only much faster than the heart rate of a normal person, but also absolutely irregular, and the atrium loses its effective contraction function. A large-scale survey in my country shows that the prevalence of AF is 0.77%. The prevalence of AF in men (0.9%) is higher than that in women (0.7%). The prevalence of AF in people over 80 years old is 7.5%. In addition, the increase in the prevalence of AF is closely related to the increase in diseases such as coronary heart disease, hypertension and heart failure. In the next 50 years, AF will become one of the most popular cardiovascular diseases.
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
Elderly -
Related symptoms:
Chest tightness brain hypoxia fatigue palpitations rapid heartbeat -
Concurrent disease:
Related Drugs
Scutellarin K injection
Indication: This product is suitable for acute congestive heart failure, especially for patients who are not responsive to digitalis. It can also be used for patients with acute heart failure and atrial fibrillation with normal or slow heart rate.
Nicorandil Tablets
Indication: It is suitable for the treatment of coronary heart disease and angina pectoris. It is effective for exertional, spontaneous, post-infarction or mixed angina pectoris. It can be used for patients with angina pectoris accompanied by atrial fibrillation, cardiac enlargement, and patients who need to use other anti-angina drugs with caution.
Manufacturer:
Topfond Pharmaceutical Co., Ltd.
Nicorandil Tablets
Indication: It is suitable for the treatment of coronary heart disease and angina pectoris. It is effective for exertional, spontaneous, post-infarction or mixed angina pectoris. It can be used for patients with angina pectoris accompanied by atrial fibrillation, cardiac enlargement, and patients who need to use other anti-angina drugs with caution.
Nicorandil Tablets
Indication: It is suitable for the treatment of coronary heart disease and angina pectoris. It is effective for exertional, spontaneous, post-infarction or mixed angina pectoris. It can be used for patients with angina pectoris accompanied by atrial fibrillation, cardiac enlargement, and patients who need to use other anti-angina drugs with caution.
Manufacturer:
Jilin Wutai Gankang Pharmaceutical Co., Ltd.
Quinidine sulfate tablets
Indication: It is mainly used for the maintenance treatment of atrial fibrillation or atrial flutter after electrical cardioversion. Although it is effective for atrial premature beats, paroxysmal supraventricular tachycardia, preexcitation syndrome with supraventricular arrhythmia, ventricular premature beats, ventricular tachycardia, and has the effect of cardioverting atrial fibrillation or atrial flutter, it is rarely used now due to many adverse reactions. Intramuscular and intravenous injections are no longer used.
Quinidine sulfate tablets
Indication: It is mainly used for the maintenance treatment of atrial fibrillation or atrial flutter after electrical cardioversion. Although it is effective for atrial premature beats, paroxysmal supraventricular tachycardia, preexcitation syndrome with supraventricular arrhythmia, ventricular premature beats, ventricular tachycardia, and has the effect of converting atrial fibrillation or atrial flutter, it is rarely used now due to many adverse reactions.
Quinidine sulfate tablets
Indication: Oral administration is mainly suitable for the maintenance treatment of atrial fibrillation or atrial flutter after electrical cardioversion. Although it is effective for atrial premature beats, paroxysmal supraventricular tachycardia, preexcitation syndrome with supraventricular arrhythmia, ventricular premature beats, ventricular tachycardia, and has the effect of cardioverting atrial fibrillation or atrial flutter, it is rarely used now due to many adverse reactions. Intramuscular and intravenous injections are no longer used.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Esmolol Hydrochloride Injection
Indication: Used to control ventricular rate in atrial fibrillation, atrial flutter, perioperative hypertension, sinus tachycardia
Manufacturer:
Huarun Shuanghe Limin Pharmaceutical (Ji'nan) Co., Ltd.
Esmolol Hydrochloride Injection
Indication: Used to control ventricular rate in atrial fibrillation, atrial flutter, perioperative hypertension, sinus tachycardia
Digoxin tablets
Indication: 1. Used for acute and chronic heart failure such as hypertension, valvular heart disease, congenital heart disease, etc. It is especially suitable for heart failure with atrial fibrillation accompanied by rapid ventricular rate; it has poor efficacy for heart failure caused by cor pulmonale, severe myocardial ischemia, active myocarditis and extracardiac factors such as severe anemia, hypothyroidism and vitamin B1 deficiency; 2. Used to control the ventricular rate and supraventricular tachycardia of patients with atrial fibrillation and atrial flutter accompanied by rapid ventricular rate.
Manufacturer:
Shanghai Yurui BIOTECHNOLOGY (Anyang) Pharmaceutical Co., Ltd.
Related Ingredients